Profil
Ei Yamada is currently the Chief Executive Officer at AnGes Euro Ltd., the Chief Executive Officer at AnGes USA, Inc., the President & Representative Director at AnGes, Inc., the Outside Director at MyBiotics Pharma Ltd., and the Director at Emendo Biotherapeutics, Inc. Dr. Yamada previously worked as a Director at Takara Bio, Inc.
Postes actifs de Ei Yamada
| Sociétés | Poste | Début |
|---|---|---|
| ANGES, INC. | President | 01/09/2002 |
| AnGes Euro Ltd. | Chief Executive Officer | 01/06/2002 |
AnGes USA, Inc.
 AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The private company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Chief Executive Officer | 01/03/2014 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Director/Board Member | 01/01/2020 |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Director/Board Member | 01/12/2018 |
Anciens postes connus de Ei Yamada
| Sociétés | Poste | Fin |
|---|---|---|
| TAKARA BIO INC. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TAKARA BIO INC. | Health Technology |
| ANGES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| AnGes Euro Ltd. | |
AnGes USA, Inc.
AnGes USA, Inc. Pharmaceuticals: MajorHealth Technology Part of AnGes, Inc., AnGes USA, Inc. develops and manufactures medicines. The private company is based in Gaithersburg, MD. Ei Yamada has been the CEO of the company since 2014. | Health Technology |
MyBiotics Pharma Ltd.
MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Health Technology |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Health Technology |
